Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMS American Shared Hospital Services	$2.53 -0.4%	$2.47	$2.27 ▼ $4.60	$16.32M	0.29	44,716 shs	3,004 shs
DVCR Diversicare Healthcare Services	$10.09 +1.0%	$10.09	$2.50 ▼ $10.09	$70.12M	0.86	18,931 shs	49,400 shs
PIII P3 Health Partners	$6.61 -0.5%	$6.83	$6.00 ▼ $32.54	$47.53M	0.78	19,818 shs	8,504 shs
XGN Exagen	$7.00 -2.5%	$6.81	$1.78 ▼ $7.95	$149.10M	1.58	145,412 shs	145,690 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMS American Shared Hospital Services	-0.39%	+2.01%	+7.17%	-5.93%	-5.22%
DVCR Diversicare Healthcare Services	0.00%	0.00%	0.00%	0.00%	0.00%
PIII P3 Health Partners	+2.15%	+6.58%	+5.56%	-28.14%	-77.30%
XGN Exagen	+2.57%	+2.57%	-7.12%	+59.91%	+250.24%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMS American Shared Hospital Services	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DVCR Diversicare Healthcare Services	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PIII P3 Health Partners	3.2669 of 5 stars	3.3	5.0	0.0	0.0	2.7	0.8	1.3
XGN Exagen	3.1505 of 5 stars	1.5	2.0	0.0	4.5	2.6	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMS American Shared Hospital Services	0.00	N/A	N/A	N/A
DVCR Diversicare Healthcare Services	0.00	N/A	N/A	N/A
PIII P3 Health Partners	2.50	Moderate Buy	$16.25	145.84% Upside
XGN Exagen	3.00	Buy	$7.50	7.14% Upside

Current Analyst Ratings Breakdown

Latest AMS, XGN, DVCR, and PIII Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/15/2025	XGN Exagen	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
5/15/2025	XGN Exagen	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$8.00 ➝ $7.00
5/13/2025	XGN Exagen	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$7.00 ➝ $8.00
5/7/2025	XGN Exagen	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
4/21/2025	PIII P3 Health Partners	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$50.00 ➝ $20.00

(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMS American Shared Hospital Services	$28.34M	0.58	$0.88 per share	2.87	$4.68 per share	0.54
DVCR Diversicare Healthcare Services	$475.72M	0.15	$5.87 per share	1.72	($4.57) per share	-2.21
PIII P3 Health Partners	$1.50B	0.03	N/A	N/A	$10.58 per share	0.62
XGN Exagen	$55.64M	2.68	N/A	N/A	$0.54 per share	12.96

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMS American Shared Hospital Services	$2.19M	$0.60	11.50	8.43	N/A	5.00%	-4.20%	-2.09%	8/13/2025 (Estimated)
DVCR Diversicare Healthcare Services	$5.16M	$0.36	28.03	∞	N/A	0.53%	-15.01%	1.05%	N/A
PIII P3 Health Partners	-$135.85M	-$47.28	N/A	N/A	N/A	-9.27%	-123.10%	-15.94%	8/6/2025 (Estimated)
XGN Exagen	-$15.11M	-$0.84	N/A	N/A	N/A	-27.34%	-133.69%	-34.87%	7/29/2025 (Estimated)

Latest AMS, XGN, DVCR, and PIII Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	AMS American Shared Hospital Services	-$0.07	N/A	N/A	N/A	$7.29 million	N/A
8/6/2025	Q2 2025	PIII P3 Health Partners	-$3.29	N/A	N/A	N/A	$356.52 million	N/A
7/29/2025	Q2 2025	XGN Exagen	-$0.18	N/A	N/A	N/A	$16.25 million	N/A
5/15/2025	Q1 2025	PIII P3 Health Partners	-$5.00	-$6.28	-$1.28	-$6.28	$362.09 million	$373.23 million
5/12/2025	Q1 2025	XGN Exagen	-$0.20	-$0.20	N/A	-$0.20	$14.55 million	$15.50 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMS American Shared Hospital Services	N/A	N/A	N/A	N/A	N/A
DVCR Diversicare Healthcare Services	N/A	N/A	N/A	N/A	N/A
PIII P3 Health Partners	N/A	N/A	N/A	N/A	N/A
XGN Exagen	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMS American Shared Hospital Services	0.58	1.87	1.87
DVCR Diversicare Healthcare Services	N/A	0.83	0.83
PIII P3 Health Partners	1.68	0.38	0.38
XGN Exagen	2.87	2.32	2.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMS American Shared Hospital Services	23.16%
DVCR Diversicare Healthcare Services	33.14%
PIII P3 Health Partners	7.75%
XGN Exagen	75.25%

Insider Ownership

Company	Insider Ownership
AMS American Shared Hospital Services	23.80%
DVCR Diversicare Healthcare Services	34.30%
PIII P3 Health Partners	17.79%
XGN Exagen	12.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMS American Shared Hospital Services	10	6.45 million	4.92 million	Not Optionable
DVCR Diversicare Healthcare Services	6,000	6.95 million	4.57 million	Not Optionable
PIII P3 Health Partners	500	7.19 million	5.91 million	Not Optionable
XGN Exagen	220	21.30 million	18.62 million	Optionable

AMS, XGN, DVCR, and PIII Headlines

Recent News About These Companies

Exagen (NASDAQ:XGN) versus Varex Imaging (NASDAQ:VREX) Head to Head Review

July 18 at 2:59 AM | americanbankingnews.com

Exagen Inc. Appoints Chas McKhann to Board of Directors

July 17 at 4:05 PM | globenewswire.com

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025

July 15 at 4:32 PM | globenewswire.com

Exagen Insider Ups Holding During Year

June 29, 2025 | finance.yahoo.com

2025-06-23 | Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics | NDAQ:XGN | Press Release - Stockhouse

June 24, 2025 | stockhouse.com

Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics

June 23, 2025 | globenewswire.com

Exagen announces resale of up to 1.15M shares

June 20, 2025 | msn.com

Exagen Inc. Holds 2025 Annual Stockholder Meeting

June 11, 2025 | tipranks.com

Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript

May 11, 2025 | insidermonkey.com

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares

May 9, 2025 | finance.yahoo.com

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares

May 9, 2025 | globenewswire.com

Exagen Inc. Prices Public Offering of Common Stock

May 8, 2025 | globenewswire.com

KeyBanc maintains Exagen stock at Sector Weight

May 7, 2025 | investing.com

KeyBanc maintains Exagen stock at Sector Weight

May 7, 2025 | investing.com

Exagen Inc. Announces Proposed Public Offering of Common Stock

May 7, 2025 | globenewswire.com

Earnings call transcript: Exagen Inc. Q1 2025 revenue beats forecasts, stock dips

May 6, 2025 | uk.investing.com

Exagen Inc. Reports Record Revenue Amid Strategic Growth

May 5, 2025 | tipranks.com

Exagen Inc. Earnings Call Highlights Record Growth

May 5, 2025 | tipranks.com

Exagen Inc. (XGN) Q1 2025 Earnings Call Transcript

May 5, 2025 | seekingalpha.com

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates

May 5, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
By Gabriel Osorio-Mazilli | July 3, 2025
View Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead

AMS, XGN, DVCR, and PIII Company Descriptions

American Shared Hospital Services NYSEAMERICAN:AMS

$2.53 -0.01 (-0.39%)

As of 04:10 PM Eastern

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

Diversicare Healthcare Services OTCMKTS:DVCR

$10.09 +0.10 (+1.00%)

As of 11/22/2021

Diversicare Healthcare Services, Inc. provides post-acute care services. The firm offers services to patients and residents including skilled nursing, ancillary health care services and assisted living. It also provides long-term care centres and rehabilitative, nutritional, respiratory and other specialized ancillary services. The company was founded in 1994 and is headquartered in Brentwood, TN.

P3 Health Partners NASDAQ:PIII

$6.61 -0.03 (-0.45%)

Closing price 04:00 PM Eastern

Extended Trading

$6.60 -0.02 (-0.23%)

As of 04:04 PM Eastern

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

Exagen NASDAQ:XGN

$7.00 -0.18 (-2.51%)

Closing price 04:00 PM Eastern

Extended Trading

$7.02 +0.01 (+0.21%)

As of 04:04 PM Eastern

Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time